Evaluation of an integrated activated partial thromboplastin time (Cephen LS /Cephen) for the detection of lupus anticoagulant
International Journal of Laboratory Hematology · 2024
DOI: 10.1111/ijlh.14349 ↗Kurz gefasst
Evaluationsstudie in der Zeitschrift International Journal of Laboratory Hematology, 2024. Verfasst von Adrien Thiriet und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratoire d'Hématologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France. Hauptthemen laut MEDLINE: Lupus Coagulation Inhibitor. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hôpitaux Universitaires de Strasbourg.
Abstract (Originalsprache)
Introduction
It is recommended to use two chronometric assays of different principles for the diagnosis of lupus anticoagulant (LA), consisting in diluted Russell Viper Venom Time (dRVVT) and activated Partial Thromboplastin Time (aPTT). Yet, there are only a few integrated aPTT assays; this study aims to evaluate one of them: Cephen LS/Cephen (Hyphen Biomed).
Method
249 samples of patients were included in this study. Normal reference ranges were determined with platelet‐poor plasma (PPP) from healthy blood donors. Performances were then evaluated by comparing Cephen LS/Cephen test results to the results of the laboratory's reference assay for the diagnosis of LA and to clinical data, both on non‐anticoagulated and anticoagulated patients' samples (Unfractioned heparin (UFH), Low Molecular Weight Heparin (LMWH), Vitamin K Antagonists (VKA) and apixaban). Interference of UFH, LMWH and VKA were also evaluated thanks to spiking experiment of increasing heparin concentrations or factor deficiency.
Results
Cephen LS/Cephen test had 48.6% sensitivity towards LA. Although UFH and VKA seemed to interfere with this assay and were likely to cause false negative, LMWH and apixaban did not. Finally, combination of Cephen LS/ Cephen with dRVVT had 89.0% sensitivity.
Conclusion
Cephen LS/Cephen seems relevant for LA diagnosis, in combination with dRVVT, and might be used in patients undergoing LMWH or apixaban therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratoire d'Hématologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
- Immunologie Clinique, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
- CNRS UMR7178, Laboratoire de Spectrométrie de Masse BioOrganique (LSMBO), Institut Pluridisciplinaire Hubert Curien, Strasbourg, France.
- CNRS UPR3572, Immunologie, Immunopathologie & Chimie Thérapeutique (I2CT), Institut de Biologie Moléculaire et Cellulaire (IBMC), Strasbourg, France.
ORCID-Profile: Agathe Herb
Förderung
- Hôpitaux Universitaires de Strasbourg
Zitieren
APA
Thiriet, A., Poindron, V., Sattler, L., Wimmer, J., Rolland, D., Korganow, A. S., Mauvieux, L., & Herb, A. (2024). Evaluation of an integrated activated partial thromboplastin time (Cephen LS /Cephen) for the detection of lupus anticoagulant. International Journal of Laboratory Hematology. https://doi.org/10.1111/ijlh.14349
Vancouver
Thiriet A, Poindron V, Sattler L, Wimmer J, Rolland D, Korganow AS, et al. Evaluation of an integrated activated partial thromboplastin time (Cephen LS /Cephen) for the detection of lupus anticoagulant. International Journal of Laboratory Hematology. 2024. doi:10.1111/ijlh.14349
BibTeX
@article{Thiriet2024,
author = {Thiriet, Adrien and Poindron, Vincent and Sattler, Laurent and Wimmer, Jordan and Rolland, Delphine and Korganow, Anne-Sophie and Mauvieux, Laurent and Herb, Agathe},
title = {Evaluation of an integrated activated partial thromboplastin time (Cephen LS /Cephen) for the detection of lupus anticoagulant},
journal = {International Journal of Laboratory Hematology},
year = {2024},
doi = {10.1111/ijlh.14349}
}
EUVIMED